Bioceltix S.A. (BCX.WA)

PLN 124.6

(0.48%)

Operating Expenses Summary of Bioceltix S.A.

  • Bioceltix S.A.'s latest annual operating expenses in 2023 was 15.38 Million PLN , up 66.73% from previous year.
  • Bioceltix S.A.'s latest quarterly operating expenses in 2024 Q2 was 3.8 Million PLN , down -15.19% from previous quarter.
  • Bioceltix S.A. reported a annual operating expenses of 9.22 Million PLN in annual operating expenses 2022, up 58.1% from previous year.
  • Bioceltix S.A. reported a annual operating expenses of 5.83 Million PLN in annual operating expenses 2021, up 4689.46% from previous year.
  • Bioceltix S.A. reported a quarterly operating expenses of 3.8 Million PLN for 2024 Q2, down -15.19% from previous quarter.
  • Bioceltix S.A. reported a quarterly operating expenses of 15.38 Million PLN for 2023 FY, up 66.73% from previous quarter.

Annual Operating Expenses Chart of Bioceltix S.A. (2023 - 2018)

Created with Highcharts 11.1.0YearsOperating Expenses20182018.520192019.520202020.520212021.520222022.520230 PLN5000000 PLN10000000 PLN15000000 PLN20000000 PLN

Historical Annual Operating Expenses of Bioceltix S.A. (2023 - 2018)

Year Operating Expenses Operating Expenses Growth
2023 15.38 Million PLN 66.73%
2022 9.22 Million PLN 58.1%
2021 5.83 Million PLN 4689.46%
2020 121.86 Thousand PLN -58.82%
2019 295.9 Thousand PLN 159.25%
2018 114.13 Thousand PLN 0.0%

Peer Operating Expenses Comparison of Bioceltix S.A.

Name Operating Expenses Operating Expenses Difference
BIOTON S.A. 57.55 Million PLN 73.271%
Captor Therapeutics Spolka Akcyjna 79.91 Million PLN 80.749%
Mabion S.A. 59.52 Million PLN 74.153%
Molecure S.A. 31.73 Million PLN 51.514%
NanoGroup S.A. 7.82 Million PLN -96.569%
Pharmena S.A. -32.76 Million PLN 146.955%
Poltreg S.A. 15.47 Million PLN 0.583%
Pure Biologics Spólka Akcyjna 29.14 Million PLN 47.211%
Ryvu Therapeutics S.A. 4.73 Million PLN -224.71%
Synthaverse S.A. 26.35 Million PLN 41.623%
Urteste S.A. 5.96 Million PLN -157.788%